Latest Insider Transactions at Medtronic PLC (MDT)
This section provides a real-time view of insider transactions for Medtronic PLC (MDT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Medtronic plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Medtronic plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 03
2022
|
Kendall J Powell Director |
SELL
Payment of exercise price or tax liability
|
Direct |
262
-0.7%
|
$26,986
$103.11 P/Share
|
|
May 03
2022
|
Richard H Anderson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
262
-0.24%
|
$26,986
$103.11 P/Share
|
|
May 03
2022
|
Andrea Jo Goldsmith Director |
SELL
Payment of exercise price or tax liability
|
Direct |
262
-5.56%
|
$26,986
$103.11 P/Share
|
|
May 02
2022
|
Craig Arnold Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,697
+4.66%
|
-
|
|
May 02
2022
|
Scott C Donnelly Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,697
+10.09%
|
-
|
|
May 02
2022
|
Randall J Hogan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,697
+27.79%
|
-
|
|
May 02
2022
|
Kevin E Lofton Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,697
+40.1%
|
-
|
|
May 02
2022
|
Elizabeth G Nabel Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,697
+12.32%
|
-
|
|
May 02
2022
|
Denise M Oleary Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,697
+2.33%
|
-
|
|
May 02
2022
|
Kendall J Powell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,697
+4.31%
|
-
|
|
May 02
2022
|
Richard H Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,697
+1.51%
|
-
|
|
May 02
2022
|
Andrea Jo Goldsmith Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,697
+26.48%
|
-
|
|
Mar 18
2022
|
Karen L Parkhill EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
682
-1.91%
|
$75,020
$110.0 P/Share
|
|
Mar 11
2022
|
Carol A Surface EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
6,000
-17.39%
|
$630,000
$105.3 P/Share
|
|
Feb 01
2022
|
Ivan K Fong EVP GENERAL COUNSEL & SECR |
BUY
Grant, award, or other acquisition
|
Direct |
30,371
+47.14%
|
-
|
|
Feb 01
2022
|
Jennifer M Kirk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
636
-7.42%
|
$65,508
$103.59 P/Share
|
|
Dec 23
2021
|
Robert John White EVP & Pres. Medical Surgical |
SELL
Open market or private sale
|
Direct |
7,218
-15.47%
|
$736,236
$102.04 P/Share
|
|
Dec 16
2021
|
Richard H Anderson Director |
BUY
Open market or private purchase
|
Direct |
5,010
+4.42%
|
$516,030
$103.26 P/Share
|
|
Dec 15
2021
|
Sean Salmon EVP & President Cardiovascular |
SELL
Payment of exercise price or tax liability
|
Direct |
89
-0.27%
|
$9,256
$104.94 P/Share
|
|
Dec 06
2021
|
Karen L Parkhill EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
682
-1.89%
|
$75,020
$110.0 P/Share
|
|
Dec 06
2021
|
Karen L Parkhill EVP & Chief Financial Officer |
BUY
Bona fide gift
|
Indirect |
49,859
+50.0%
|
-
|
|
Dec 06
2021
|
Karen L Parkhill EVP & Chief Financial Officer |
SELL
Bona fide gift
|
Indirect |
49,859
-100.0%
|
-
|
|
Nov 05
2021
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Payment of exercise price or tax liability
|
Direct |
209
-0.28%
|
$25,498
$122.98 P/Share
|
|
Nov 05
2021
|
Bradley E Lerman SVP General Counsel & Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
250
-0.51%
|
$30,500
$122.98 P/Share
|
|
Nov 05
2021
|
John R Liddicoat EVP & President of Americas |
SELL
Payment of exercise price or tax liability
|
Direct |
139
-0.32%
|
$16,958
$122.98 P/Share
|
|
Nov 05
2021
|
Sean Salmon EVP & President Cardiovascular |
SELL
Payment of exercise price or tax liability
|
Direct |
245
-0.73%
|
$29,890
$122.98 P/Share
|
|
Nov 05
2021
|
Brett A. Wall EVP & Pres Neuroscience |
SELL
Payment of exercise price or tax liability
|
Direct |
238
-0.93%
|
$29,036
$122.98 P/Share
|
|
Nov 05
2021
|
Robert John White EVP & Pres. Medical Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
246
-0.52%
|
$30,012
$122.98 P/Share
|
|
Nov 01
2021
|
Hoedt Rob Ten EVP and Pres. Global Regions |
BUY
Grant, award, or other acquisition
|
Direct |
832
+1.8%
|
-
|
|
Oct 08
2021
|
Karen L Parkhill EVP & Chief Financial Officer |
BUY
Bona fide gift
|
Indirect |
12,000
+19.4%
|
-
|
|
Oct 08
2021
|
Karen L Parkhill EVP & Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
12,000
-25.01%
|
-
|
|
Oct 06
2021
|
Karen L Parkhill EVP & Chief Financial Officer |
BUY
Bona fide gift
|
Indirect |
37,859
+50.0%
|
-
|
|
Oct 06
2021
|
Karen L Parkhill EVP & Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
37,859
-44.11%
|
-
|
|
Sep 30
2021
|
Bradley E Lerman SVP General Counsel & Corp Sec |
SELL
Open market or private sale
|
Direct |
49,147
-50.2%
|
$6,192,522
$126.58 P/Share
|
|
Sep 30
2021
|
Bradley E Lerman SVP General Counsel & Corp Sec |
BUY
Exercise of conversion of derivative security
|
Direct |
49,147
+33.42%
|
$3,833,466
$78.0 P/Share
|
|
Aug 31
2021
|
Bradley E Lerman SVP General Counsel & Corp Sec |
SELL
Open market or private sale
|
Direct |
50,775
-51.01%
|
$6,803,850
$134.17 P/Share
|
|
Aug 31
2021
|
Bradley E Lerman SVP General Counsel & Corp Sec |
BUY
Exercise of conversion of derivative security
|
Direct |
50,775
+33.78%
|
$3,757,350
$74.84 P/Share
|
|
Aug 25
2021
|
Geoffrey Martha Chairman and CEO |
SELL
Open market or private sale
|
Direct |
11,581
-5.53%
|
$1,528,692
$132.67 P/Share
|
|
Aug 25
2021
|
Geoffrey Martha Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,581
+5.1%
|
$683,279
$59.04 P/Share
|
|
Aug 25
2021
|
Sean Salmon EVP & President Cardiovascular |
SELL
Open market or private sale
|
Direct |
28,419
-28.37%
|
$3,808,146
$134.08 P/Share
|
|
Aug 25
2021
|
Sean Salmon EVP & President Cardiovascular |
BUY
Exercise of conversion of derivative security
|
Direct |
28,419
+15.02%
|
$1,079,922
$38.61 P/Share
|
|
Aug 02
2021
|
Jennifer M Kirk Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,143
+11.99%
|
-
|
|
Aug 02
2021
|
Richard Kuntz SVP & Chief Medical & Science |
BUY
Grant, award, or other acquisition
|
Direct |
5,029
+6.29%
|
-
|
|
Aug 02
2021
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Payment of exercise price or tax liability
|
Direct |
4,905
-6.56%
|
$642,555
$131.31 P/Share
|
|
Aug 02
2021
|
Bradley E Lerman SVP General Counsel & Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct |
6,019
+10.99%
|
-
|
|
Aug 02
2021
|
Bradley E Lerman SVP General Counsel & Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
5,450
-11.31%
|
$713,950
$131.31 P/Share
|
|
Aug 02
2021
|
Bradley E Lerman SVP General Counsel & Corp Sec |
SELL
Open market or private sale
|
Direct |
4,000
-7.66%
|
$524,000
$131.52 P/Share
|
|
Aug 02
2021
|
John R Liddicoat EVP & President of Americas |
BUY
Grant, award, or other acquisition
|
Direct |
3,353
+7.26%
|
-
|
|
Aug 02
2021
|
John R Liddicoat EVP & President of Americas |
SELL
Payment of exercise price or tax liability
|
Direct |
3,258
-7.62%
|
$426,798
$131.31 P/Share
|
|
Aug 02
2021
|
Geoffrey Martha Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
19,047
+16.58%
|
-
|